Can-Fite BioPharma Ltd. Right-of-Use Asset Obtained in Exchange for Operating Lease Liability
Can-Fite BioPharma Ltd. (CANF) reported Right-of-Use Asset Obtained in Exchange for Operating Lease Liability of $96.00 thousand for the 12-month period ending 2024-12-31, per its 20-F filed 2025-04-14.
Financial Statements › Notes › Leases
us-gaap:RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability · last filed 2025-04-14
| Period end | Right-of-Use Asset Obtained in Exchange for Operating Lease Liability 6 month | Right-of-Use Asset Obtained in Exchange for Operating Lease Liability 12 month | Right-of-Use Asset Obtained in Exchange for Operating Lease Liability 12 month as first filed |
|---|---|---|---|
| 2024-12-31 | $96.00K 20-F · filed 2025-04-14 | ||
| 2024-06-30 | $14.00K 6-K · filed 2024-08-29 | ||
| 2023-12-31 | $62.00K 20-F · filed 2025-04-14 | ||
| 2023-06-30 | $32.00K 6-K · filed 2024-08-29 | ||
| 2022-06-30 | $27.00K 6-K · filed 2022-08-25 | ||
| 2021-12-31 | $120.00K 20-F · filed 2024-03-28 | ||
| 2021-06-30 | $19.00K 6-K · filed 2022-08-25 | ||
| 2020-12-31 | $29.00K 20-F · filed 2023-03-30 | ||
| 2020-06-30 | $16.00K 6-K · filed 2021-08-26 | ||
| 2019-12-31 | $76.00K 20-F · filed 2022-03-24 | $28.00K 6-K · filed 2020-06-01 |